Paul Tudor Jones Sage Therapeutics, Inc. Transaction History

Tudor Investment Corp Et Al

$26.8 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$10.58 - $17.9 $176,326 - $298,321	16,666 Added 125.34%	29,963 $325,000
Q1 2024 May 15, 2024	SELL	$18.62 - $26.95 $309,855 - $448,474	-16,641 Reduced 55.58%	13,297 $249,000
Q4 2023 Feb 14, 2024	SELL	$17.1 - $22.26 $354,414 - $461,360	-20,726 Reduced 40.91%	29,938 $648,000
Q3 2023 Nov 15, 2023	BUY	$16.75 - $48.98 $499,836 - $1.46 Million	29,841 Added 143.31%	50,664 $1.04 Million
Q2 2023 Aug 14, 2023	SELL	$40.65 - $59.54 $426,825 - $625,170	-10,500 Reduced 33.52%	20,823 $979,000
Q1 2023 May 15, 2023	BUY	$37.27 - $46.57 $1.17 Million - $1.46 Million	31,323 New	31,323 $1.31 Million
Q3 2022 Nov 14, 2022	SELL	$32.28 - $43.27 $644,244 - $863,582	-19,958 Reduced 53.7%	17,207 $674,000
Q2 2022 Aug 15, 2022	BUY	$27.52 - $37.99 $1.02 Million - $1.41 Million	37,165 New	37,165 $1.2 Million
Q1 2021 May 17, 2021	SELL	$70.65 - $96.76 $351,695 - $481,671	-4,978 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$58.41 - $89.06 $290,764 - $443,340	4,978 New	4,978 $431,000
Q3 2020 Nov 16, 2020	SELL	$41.13 - $62.45 $214,163 - $325,177	-5,207 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$25.95 - $43.15 $135,121 - $224,682	5,207 New	5,207 $217,000
Q1 2020 May 15, 2020	SELL	$26.15 - $77.24 $213,540 - $630,741	-8,166 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$60.18 - $154.77 $491,429 - $1.26 Million	8,166 New	8,166 $590,000
Q3 2018 Nov 14, 2018	SELL	$138.11 - $169.04 $737,645 - $902,842	-5,341 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$140.36 - $175.76 $749,662 - $938,734	5,341 New	5,341 $836,000
Q1 2018 May 15, 2018	SELL	$152.15 - $192.33 $214,227 - $270,800	-1,408 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$60.72 - $167.34 $206,873 - $570,127	-3,407 Reduced 70.76%	1,408 $232,000
Q3 2017 Nov 14, 2017	BUY	$61.4 - $88.52 $295,641 - $426,223	4,815	4,815 $300,000

Others Institutions Holding SAGE

# of Institutions

198

Shares Held

46.5M

Call Options Held

402K

Put Options Held

209K

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $326M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track Paul Tudor Jones's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Account